Recombinant CD25 anticorps (AA 22-213)
Aperçu rapide pour Recombinant CD25 anticorps (AA 22-213) (ABIN7453339)
Antigène
Voir toutes CD25 (IL2RA) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 22-213
-
Fonction
- Rabbit anti-CD25/IL-2R alpha Recombinant Monoclonal Antibody [BLR157J]
-
Immunogène
- residues 22-213 (ECD)
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 20 μL/1 mg lysate
ICC: 1:100 to 1:500. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE cell sections.
WB: 01:01,00
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- CD25 (IL2RA) (Interleukin 2 Receptor, alpha (IL2RA))
-
Autre désignation
- CD25/IL-2R alpha
-
Sujet
- Background: The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. The IL2 receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells. [taken from NCBI Entrez Gene (Gene ID: 3559)].
-
ID gène
- 3559
-
NCBI Accession
- NP_000408
-
UniProt
- P01589
-
Pathways
- Signalistation JAK/STAT, Growth Factor Binding, Activated T Cell Proliferation
Antigène
-